Search

everythinglearnresearchcommunity

for

Search:↓

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

XEDAR triggers a specific signaling pathway in cells.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Viruses continue to challenge human health despite medical advances.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Methadone may worsen liver fibrosis in males with HCV.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Extracellular vesicles are important for disease treatment and monitoring.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Certain medications can cause serious side effects, so it's important to report them.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The E2 protein affects gene activity in hair follicles of mice.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.